Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

Ainnocence’s CarbonAI® Platform for AI-Powered Small Molecule Drug Design — Enabling De Novo Generation, Lead Optimization, ...

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ETCompany ParticipantsJustine Koenigsberg - Vice President ...

Stoneridge has unveiled a new second-generation smart tachograph from its SE5000 series, featuring a satellite-based ...

Ainnocence, a leader in next-generation AI drug-discovery solutions, today released a comprehensive white paper detailing ...

A study has found that an ancient protein motif that binds to nucleic acids is functionally "ambidextrous." This means that ...

(RTTNews) - Woodside Energy Ltd said that the company and Aramco reached a non-binding collaboration agreement to explore global opportunities, including Aramco's potential acquisition of an ...

THG has rejected an offer from cash shell Selkirk to acquire Myprotein which it dismissed as “wholly unsolicited, largely unfunded, highly conditional and non-binding”. Selkirk’s offer ...

Several human pathogens exploit the kinetic forces generated by polymerizing actin to power their intracellular motility. Human cell-autonomous immune responses activate ...